Skip to main content

Table 2 Screening for viral hepatitis and hepatitis B vaccinations among individuals aged between 15 and 64 years according to sex and age in Brazil as measured by the in the PCAP-2013

From: State of viral hepatitis knowledge and testing uptake in Brazil: Findings from the National Survey of Knowledge, Attitudes and Practices (PCAP-2013)

  

Men

Women

Total

15–24

25–49

50–64

All age groups

p-value

15–24

25–49

50–64

All age groups

p-value

VH screening, ever

29 (27.6–30.4)

14.3 (11.9–17.1)

27.7 (25.6–29.9)

25.5 (22.3–28.9)

23.7 (22.1–25.3)

<0.001

24.5 (21.6–27.6)

41 (38.4–43.6)

26.6 (23.8–29.6)

34 (32–36)

<0.001

HBV

44.6 (42.2–47.2)

46.2 (37.2–55.5)

47.4 (42.9–52)

39.9 (33–47.3)

45.8 (42–49.6)

0.25

49.4 (42.9–55.9)

43.6 (39.8–47.5)

38.5 (32.5–44.8)

43.9 (40.1–47.2)

0.05

HCV

32 (29.7–34.5)

36.3 (27.6–46.1)

33.5 (29.2–38)

32.8 (26.4–40)

33.8 (30.3–37.6)

0.79

29.3 (23.2–36.4)

31.5 (27.9–35.4)

29.8 (24.1–36.2)

30.8 (27.7–34.1)

0.77

HDV

16.8 (13.7–19)

15.7 (10–23.8)

16.8 (13.8–20.3)

14.5 (10.3–20.1)

16.2 (16.7–19)

0.77

17.6 (12.4–24.3)

16.9 (14.1–20.1)

14.9 (10.8–20.2)

16.7 (14.2–19.6)

0.73

VH screening, last 12 months

36.2 (35.5–42.7)

38.5 (29.7–48)

40 (35.7–44.5)

36.3 (29.5–43.8)

39.1 (35.5–42.7)

0.70

45 (38.4–51.7)

33.2 (29.5–37.1)

26.3 (21–32.3)

34.3 (31.4–37.2)

0.0003

VH screening using rapid testing, ever

17.5 (15.6–19.6)

16.2 (10.1–25.1)

21 (17.3–25.2)

16.3 (11.8–22.2)

19.3 (16.5–22.4)

0.31

24 (18.2–31.1)

14.7 (12.1–17.8)

14.1 (10.1–19.3)

16.3 (13.8–19.2)

0.002

Knowledge of last VH test results

89.9 (88.3–91.3)

84.2 (75.2–90.4)

88.7 (84.7–91.8)

89.9 (84.3–93.7)

88.3 (85.2–90.7)

0.36

89.8 (85.5–93)

91.4 (89–93.3)

90.2 (86.6–93)

90.9 (89–92.5)

0.61

Knowledge of any health service that offers free screening for VH

38.7 (37–40.5)

26 (23–29.2)

34.6 (32.1–37.3)

33.3 (29.9–36.9)

32.1 (30–34.2)

<0.001

36 (32.8–40)

50.4 (47.6–53.3)

42.3 (38.9–46)

45.1 (42.7–47.5)

<0.001

HBV vaccination (1 dose)

73.9 (72.4–75.4)

68.8 (65.3–72)

71.3 (68.6–73.8)

72.2 (68.8–75.4)

70.8 (68.5–73)

0.19

76.8 (73.9–79.5)

76.4 (74–78.6)

78.6 (75.8–81.2)

76.9 (75–78.8)

0.38

HBV vaccination (3 doses)

18.3 (17.0–19.6)

10.3 (8.4–12.5)

14.3 (12.6–16.3)

12.8 (10.6–15.3)

13.0 (11.6–14.5)

0.01

24.7 (22.0–27.6)

24.6 (22.2–27.2)

17.9 (15.5–20.5)

23.3 (21.3–25.5)

<0.001

Denominators

Unweighted

12000

1503

3002

1495

6000

1499

3002

1499

6000

Weighted

12000

1577

3208

1081

5867

1565

3362

1207

6133

  1. ... not statistically significant